Medical test and drug development technologies from UW Bioengineering have spun out into start-ups Nexgenia and Nanosurface Biomedical, with Coulter’s help.
Ph.D. student’s idea for device that diagnoses tuberculosis from urine leads to Global WACh/W.H. Coulter Foundation Seed Grant
An interdisciplinary research team led by PIs Drs. James Lai and Barry Lutz of UW Bioengineering and UW tuberculosis researcher-clinician Dr. David Horne has received the 2014 Global WACh/W.H. Coulter Foundation Seed Grant to develop a point-of-care diagnostic device to diagnose TB from urine samples. The idea originated from a proposal developed by UW BioE student Nuttada Panpradist and UW MPH student and pediatrician Dr. Diana Marangu in a Global Health course, GH 590, “Bioengineering Solutions to Improve the Health of Women, Adolescents and Children”.
The world does not yet have a Star Trek tricorder. But UW bioengineers are developing devices and technology that may be powerful precursors to Dr. McCoy’s handy 23rd century diagnostic device, and may make improving health faster and easier than ever before. Researchers are answering the call for accessible, rapid testing tools, which can speed the time until treatment starts, helping prevent deaths, outbreaks and disability.